Yoland Antill

2.8k total citations
46 papers, 800 citations indexed

About

Yoland Antill is a scholar working on Oncology, Obstetrics and Gynecology and Pathology and Forensic Medicine. According to data from OpenAlex, Yoland Antill has authored 46 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Obstetrics and Gynecology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Yoland Antill's work include Endometrial and Cervical Cancer Treatments (16 papers), Genetic factors in colorectal cancer (13 papers) and BRCA gene mutations in cancer (10 papers). Yoland Antill is often cited by papers focused on Endometrial and Cervical Cancer Treatments (16 papers), Genetic factors in colorectal cancer (13 papers) and BRCA gene mutations in cancer (10 papers). Yoland Antill collaborates with scholars based in Australia, United Kingdom and Japan. Yoland Antill's co-authors include Mark J. Haykowsky, Erin J. Howden, Sherene Loi, André La Gerche, Stephen Foulkes, Steve F. Fraser, Sophie Nightingale, Ashley Bigaran, Linda Mileshkin and Jeffrey C. Goh and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Yoland Antill

43 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoland Antill Australia 16 384 224 185 174 130 46 800
Alison H. Brand Australia 21 549 1.4× 77 0.3× 461 2.5× 544 3.1× 112 0.9× 73 1.4k
Maria D. Iniesta United States 16 418 1.1× 593 2.6× 212 1.1× 171 1.0× 137 1.1× 62 1.4k
Arif Kökçü Türkiye 18 165 0.4× 26 0.1× 366 2.0× 364 2.1× 38 0.3× 53 822
Ron Auslender Israel 17 92 0.2× 54 0.2× 271 1.5× 591 3.4× 45 0.3× 68 1.2k
Luciano de Melo Pompei Brazil 12 100 0.3× 29 0.1× 98 0.5× 38 0.2× 84 0.6× 57 625
Maryam Shahidi Iran 17 438 1.1× 68 0.3× 204 1.1× 16 0.1× 45 0.3× 51 1.2k
E. Pras Netherlands 11 169 0.4× 24 0.1× 95 0.5× 243 1.4× 58 0.4× 20 621
Philip D. Poorvu United States 15 345 0.9× 12 0.1× 145 0.8× 66 0.4× 51 0.4× 44 718
Michael W. Bevers United States 15 311 0.8× 11 0.0× 480 2.6× 623 3.6× 60 0.5× 27 1.3k
Peter Grant Australia 21 266 0.7× 13 0.1× 517 2.8× 359 2.1× 91 0.7× 58 1.2k

Countries citing papers authored by Yoland Antill

Since Specialization
Citations

This map shows the geographic impact of Yoland Antill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoland Antill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoland Antill more than expected).

Fields of papers citing papers by Yoland Antill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoland Antill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoland Antill. The network helps show where Yoland Antill may publish in the future.

Co-authorship network of co-authors of Yoland Antill

This figure shows the co-authorship network connecting the top 25 collaborators of Yoland Antill. A scholar is included among the top collaborators of Yoland Antill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoland Antill. Yoland Antill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kok, Peey‐Sei, Yoland Antill, Clare L. Scott, et al.. (2024). Impact of chemotherapy on patients with mismatch repair deficient advanced endometrial carcinomas—a meta-analysis. JNCI Cancer Spectrum. 8(6). 2 indexed citations
3.
Howden, Erin J., Stephen Foulkes, Mark J. Haykowsky, et al.. (2023). Effects Of 12-months Of Exercise Training On Determinants Of Vo2Peak In Anthracycline-treated Breast Cancer Survivors. Medicine & Science in Sports & Exercise. 55(9S). 968–968. 1 indexed citations
4.
Evans, Sue, John Zalcberg, Yoland Antill, et al.. (2023). Registry-derived stage (RD-Stage) for capturing cancer stage at diagnosis for endometrial cancer. BMC Cancer. 23(1). 1222–1222. 3 indexed citations
5.
Foulkes, Stephen, Erin J. Howden, Mark J. Haykowsky, et al.. (2022). Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study. Circulation. 147(7). 532–545. 64 indexed citations
6.
Smith, Deborah S., Kristy Robledo, Sonia Yip, et al.. (2022). Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA). Cancers. 15(1). 254–254. 1 indexed citations
7.
Antill, Yoland, et al.. (2022). The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis. ESMO Open. 7(6). 100635–100635. 6 indexed citations
8.
Yanes, Tatiane, Bettina Meiser, Rajneesh Kaur, et al.. (2021). Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior. Genetics in Medicine. 23(12). 2316–2323. 15 indexed citations
9.
10.
Yanes, Tatiane, Rajneesh Kaur, Bettina Meiser, et al.. (2020). Women’s responses and understanding of polygenic breast cancer risk information. Familial Cancer. 19(4). 297–306. 15 indexed citations
11.
12.
Tang, Mónica, Rachel O’Connell, Frédéric Amant, et al.. (2019). PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors. Gynecologic Oncology. 154(3). 531–538. 54 indexed citations
13.
Yanes, Tatiane, Bettina Meiser, Rajneesh Kaur, et al.. (2018). Polygenic breast cancer risk: A prospective study of uptake and outcomes among high-risk women. Twin Research and Human Genetics. 1 indexed citations
14.
Haydon, Andrew, Lewis Au, Simon Wilkins, et al.. (2018). Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres. International Journal of Surgery. 51. 71–75. 6 indexed citations
15.
Meiser, Bettina, Veronica Quinn, Gillian Mitchell, et al.. (2018). Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history. European Journal of Human Genetics. 26(7). 972–983. 12 indexed citations
16.
Smith, Kortnye, Julie Winstanley, F. Boyle, et al.. (2017). Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy. Supportive Care in Cancer. 26(2). 483–489. 11 indexed citations
17.
18.
Meiser, Bettina, Veronica Quinn, Margaret Gleeson, et al.. (2016). When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer. European Journal of Human Genetics. 24(11). 1517–1523. 11 indexed citations
19.
Win, Aung Ko, James G. Dowty, Yoland Antill, et al.. (2011). Body Mass Index in Early Adulthood and Endometrial Cancer Risk for Mismatch Repair Gene Mutation Carriers. Obstetrics and Gynecology. 117(4). 899–905. 14 indexed citations
20.
Duffy, David L., et al.. (2011). Report of Endometrial Cancer in AustralianBRCA1andBRCA2Mutation-Positive Families. Twin Research and Human Genetics. 14(2). 111–118. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alison H. Brand Breakdown of academic impact, for papers by Maria D. Iniesta Breakdown of academic impact, for papers by Arif Kökçü Breakdown of academic impact, for papers by Ron Auslender Breakdown of academic impact, for papers by Luciano de Melo Pompei Breakdown of academic impact, for papers by Maryam Shahidi Breakdown of academic impact, for papers by E. Pras Breakdown of academic impact, for papers by Philip D. Poorvu Breakdown of academic impact, for papers by Michael W. Bevers Breakdown of academic impact, for papers by Peter Grant
Rankless by CCL
2026